NASDAQ:KROS

Keros Therapeutics Stock News

etoro logo Buy KROS
*Your capital is at risk
$11.15
+0.500 (+4.69%)
At Close: Aug 07, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) * Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) * Ar
Company also exceeds offering target Continue reading...
Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO, Stocks: KROS,XLRN,TSE:4503,BMY,FGEN,SRRA,IMRA,ZNTL, release date:Apr 21, 2020

Weekly CEO Buys Highlight

02:40pm, Monday, 20'th Apr 2020
Details the CEO buys this past week for the following companies: Ryman Hospitality Properties, OPKO Health, Keros Therapeutics and Spirit Realty Capital Continue reading...

Weekly CEO Buys Highlight

01:54pm, Monday, 20'th Apr 2020
Weekly CEO Buys Highlight, Stocks: RHP,OPK,KROS,SRC, release date:Apr 19, 2020
Fly Insider: Gamestop, SharpSpring among week's notable insider trades NBIX GME BSET KWR KROS TGE SHSP WDAY MRVL PEN
Insider purchases tend to yield strong returns which makes it an interesting strategy to analyse. My thesis shows abnormal returns of 13.25% annually. Each week
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs April 14) * Bio-Rad Laboratories, Inc. (NYSE: BIO) * Accelero
The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) * Chembio Diagnostics Inc (NASDAQ: CEMI)
Keros Therapeutics, Inc. (“Keros”) (KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from he
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19...
Keros Therapeutics finished the week up 35%, affirming that the biotech industry won't be deterred by current market volatility. The IPO Index jumped 11.3% this
The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 8) * Keros Therapeutics Inc (NASDAQ: KROS) (went public
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE